On a scale of 0 to 100, Ryman Healthcare holds a performance score of 10. The company holds a Beta of 0.37, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Ryman Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ryman Healthcare is expected to be smaller as well. Please check Ryman Healthcare's skewness, as well as the relationship between the rate of daily change and price action indicator , to make a quick decision on whether Ryman Healthcare's historical price patterns will revert.
Risk-Adjusted Performance
Fair
Weak
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ryman Healthcare Ltd are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Ryman Healthcare showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow
20.2 M
Total Cashflows From Investing Activities
-787.3 M
Ryman
Ryman Healthcare Relative Risk vs. Return Landscape
If you would invest 711.00 in Ryman Healthcare Ltd on September 29, 2025 and sell it today you would earn a total of 120.00 from holding Ryman Healthcare Ltd or generate 16.88% return on investment over 90 days. Ryman Healthcare Ltd is currently producing 0.2626% returns and takes up 2.0072% volatility of returns over 90 trading days. Put another way, 18% of traded pink sheets are less volatile than Ryman, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
Expected Return
Risk
Assuming the 90 days horizon Ryman Healthcare is expected to generate 2.84 times more return on investment than the market. However, the company is 2.84 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.
Ryman Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ryman Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ryman Healthcare Ltd, and traders can use it to determine the average amount a Ryman Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1308
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
RYHTY
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
Based on monthly moving average Ryman Healthcare is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ryman Healthcare by adding it to a well-diversified portfolio.
Ryman Healthcare Fundamentals Growth
Ryman Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ryman Healthcare, and Ryman Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ryman Pink Sheet performance.
Evaluating Ryman Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ryman Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ryman Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. Ryman Healthcare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 6700 people.
Things to note about Ryman Healthcare performance evaluation
Checking the ongoing alerts about Ryman Healthcare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ryman Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ryman Healthcare Ltd has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity.
Evaluating Ryman Healthcare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ryman Healthcare's pink sheet performance include:
Analyzing Ryman Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ryman Healthcare's stock is overvalued or undervalued compared to its peers.
Examining Ryman Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Ryman Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ryman Healthcare's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Ryman Healthcare's pink sheet. These opinions can provide insight into Ryman Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ryman Healthcare's pink sheet performance is not an exact science, and many factors can impact Ryman Healthcare's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Ryman Pink Sheet Analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.